-
2
-
-
84944871061
-
Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer
-
Bowtell DD, Bohm S, Ahmed AA, Aspuria PJ, Bast Jr RC, Beral V, et al. Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer. Nat Rev Cancer. 2015;15(11):668-79.
-
(2015)
Nat Rev Cancer
, vol.15
, Issue.11
, pp. 668-679
-
-
Bowtell, D.D.1
Bohm, S.2
Ahmed, A.A.3
Aspuria, P.J.4
Bast, R.C.5
Beral, V.6
-
3
-
-
0020559574
-
A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer
-
Bast Jr RC, Klug TL, St JE, Jenison E, Niloff JM, Lazarus H, et al. A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer. N Engl J Med. 1983;309(15):883-7.
-
(1983)
N Engl J Med
, vol.309
, Issue.15
, pp. 883-887
-
-
Bast, R.C.1
Klug, T.L.2
St, J.E.3
Jenison, E.4
Niloff, J.M.5
Lazarus, H.6
-
4
-
-
79958036419
-
Effect of screening on ovarian cancer mortality: the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Randomized Controlled Trial
-
Buys SS, Partridge E, Black A, Johnson CC, Lamerato L, Isaacs C, et al. Effect of screening on ovarian cancer mortality: the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Randomized Controlled Trial. JAMA. 2011;305(22):2295-303.
-
(2011)
JAMA
, vol.305
, Issue.22
, pp. 2295-2303
-
-
Buys, S.S.1
Partridge, E.2
Black, A.3
Johnson, C.C.4
Lamerato, L.5
Isaacs, C.6
-
5
-
-
79953043818
-
Ovarian cancer biomarker performance in prostate, lung, colorectal, and ovarian cancer screening trial specimens
-
Cramer DW, Bast Jr RC, Berg CD, Diamandis EP, Godwin AK, Hartge P, et al. Ovarian cancer biomarker performance in prostate, lung, colorectal, and ovarian cancer screening trial specimens. Cancer Prev Res (Phila). 2011;4(3):365-74.
-
(2011)
Cancer Prev Res (Phila)
, vol.4
, Issue.3
, pp. 365-374
-
-
Cramer, D.W.1
Bast, R.C.2
Berg, C.D.3
Diamandis, E.P.4
Godwin, A.K.5
Hartge, P.6
-
6
-
-
84959863810
-
Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial
-
10022.
-
Jacobs IJ, Menon U, Ryan A, Gentry-Maharaj A, Burnell M, Kalsi JK, et al. Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial. Lancet. 2016;387(10022):945-56.
-
(2016)
Lancet
, vol.387
, pp. 945-956
-
-
Jacobs, I.J.1
Menon, U.2
Ryan, A.3
Gentry-Maharaj, A.4
Burnell, M.5
Kalsi, J.K.6
-
7
-
-
84930654984
-
Risk algorithm using serial biomarker measurements doubles the number of screen-detected cancers compared with a single-threshold rule in the United Kingdom Collaborative Trial of Ovarian Cancer Screening
-
Menon U, Ryan A, Kalsi J, Gentry-Maharaj A, Dawnay A, Habib M, et al. Risk algorithm using serial biomarker measurements doubles the number of screen-detected cancers compared with a single-threshold rule in the United Kingdom Collaborative Trial of Ovarian Cancer Screening. J Clin Oncol. 2015;33(18):2062-71.
-
(2015)
J Clin Oncol
, vol.33
, Issue.18
, pp. 2062-2071
-
-
Menon, U.1
Ryan, A.2
Kalsi, J.3
Gentry-Maharaj, A.4
Dawnay, A.5
Habib, M.6
-
8
-
-
84925282761
-
Serum HE4 and CA125 as predictors of response and outcome during neoadjuvant chemotherapy of advanced high-grade serous ovarian cancer
-
Vallius T, Hynninen J, Auranen A, Carpen O, Matomaki J, Oksa S, et al. Serum HE4 and CA125 as predictors of response and outcome during neoadjuvant chemotherapy of advanced high-grade serous ovarian cancer. Tumour Biol. 2014;35(12):12389-95.
-
(2014)
Tumour Biol
, vol.35
, Issue.12
, pp. 12389-12395
-
-
Vallius, T.1
Hynninen, J.2
Auranen, A.3
Carpen, O.4
Matomaki, J.5
Oksa, S.6
-
9
-
-
34248329991
-
The lack of significance of Ca125 response in epithelial ovarian cancer patients treated with neoadjuvant chemotherapy and delayed primary surgical debulking
-
Le T, Hopkins L, Faught W, Fung-Kee-Fung M. The lack of significance of Ca125 response in epithelial ovarian cancer patients treated with neoadjuvant chemotherapy and delayed primary surgical debulking. Gynecol Oncol. 2007;105(3):712-5.
-
(2007)
Gynecol Oncol
, vol.105
, Issue.3
, pp. 712-715
-
-
Le, T.1
Hopkins, L.2
Faught, W.3
Fung-Kee-Fung, M.4
-
10
-
-
84984563841
-
Dynamic analysis of CA125 decline during neoadjuvant chemotherapy in patients with epithelial ovarian cancer as a predictor for platinum sensitivity
-
Pelissier A, Bonneau C, Chereau E, DE LA Motte RT, Fourchotte V, Darai E, et al. Dynamic analysis of CA125 decline during neoadjuvant chemotherapy in patients with epithelial ovarian cancer as a predictor for platinum sensitivity. Anticancer Res. 2016;36(4):1865-71.
-
(2016)
Anticancer Res
, vol.36
, Issue.4
, pp. 1865-1871
-
-
Pelissier, A.1
Bonneau, C.2
Chereau, E.3
Motte, R.T.4
Fourchotte, V.5
Darai, E.6
-
11
-
-
84920733816
-
CA125 kinetic parameters predict optimal cytoreduction in patients with advanced epithelial ovarian cancer treated with neoadjuvant chemotherapy
-
Pelissier A, Bonneau C, Chereau E, DE LA Motte RT, Fourchotte V, Darai E, et al. CA125 kinetic parameters predict optimal cytoreduction in patients with advanced epithelial ovarian cancer treated with neoadjuvant chemotherapy. Gynecol Oncol. 2014;135(3):542-6.
-
(2014)
Gynecol Oncol
, vol.135
, Issue.3
, pp. 542-546
-
-
Pelissier, A.1
Bonneau, C.2
Chereau, E.3
Motte, R.T.4
Fourchotte, V.5
Darai, E.6
-
12
-
-
84875520648
-
Analysis of circulating tumor DNA to monitor metastatic breast cancer
-
Dawson SJ, Tsui DW, Murtaza M, Biggs H, Rueda OM, Chin SF, et al. Analysis of circulating tumor DNA to monitor metastatic breast cancer. N Engl J Med. 2013;368(13):1199-209.
-
(2013)
N Engl J Med
, vol.368
, Issue.13
, pp. 1199-1209
-
-
Dawson, S.J.1
Tsui, D.W.2
Murtaza, M.3
Biggs, H.4
Rueda, O.M.5
Chin, S.F.6
-
13
-
-
84877579861
-
Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA
-
Murtaza M, Dawson SJ, Tsui DW, Gale D, Forshew T, Piskorz AM, et al. Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA. Nature. 2013;497(7447):108-12.
-
(2013)
Nature
, vol.497
, Issue.7447
, pp. 108-112
-
-
Murtaza, M.1
Dawson, S.J.2
Tsui, D.W.3
Gale, D.4
Forshew, T.5
Piskorz, A.M.6
-
14
-
-
84937611698
-
Detection of somatic mutations and HPV in the saliva and plasma of patients with head and neck squamous cell carcinomas
-
Wang Y, Springer S, Mulvey CL, Silliman N, Schaefer J, Sausen M, et al. Detection of somatic mutations and HPV in the saliva and plasma of patients with head and neck squamous cell carcinomas. Sci Transl Med. 2015;7(293):293ra104.
-
(2015)
Sci Transl Med
, vol.7
, Issue.293
-
-
Wang, Y.1
Springer, S.2
Mulvey, C.L.3
Silliman, N.4
Schaefer, J.5
Sausen, M.6
-
15
-
-
84937205362
-
Clonal evolution and resistance to EGFR blockade in the blood of colorectal cancer patients
-
Siravegna G, Mussolin B, Buscarino M, Corti G, Cassingena A, Crisafulli G, et al. Clonal evolution and resistance to EGFR blockade in the blood of colorectal cancer patients. Nat Med. 2015;21(7):827.
-
(2015)
Nat Med
, vol.21
, Issue.7
, pp. 827
-
-
Siravegna, G.1
Mussolin, B.2
Buscarino, M.3
Corti, G.4
Cassingena, A.5
Crisafulli, G.6
-
16
-
-
84896371874
-
Detection of circulating tumor DNA in early- and late-stage human malignancies
-
Bettegowda C, Sausen M, Leary RJ, Kinde I, Wang Y, Agrawal N, et al. Detection of circulating tumor DNA in early- and late-stage human malignancies. Sci Transl Med. 2014;6(224):224ra224.
-
(2014)
Sci Transl Med
, vol.6
, Issue.224
, pp. 224ra224
-
-
Bettegowda, C.1
Sausen, M.2
Leary, R.J.3
Kinde, I.4
Wang, Y.5
Agrawal, N.6
-
17
-
-
84949009842
-
Analytical and clinical validation of a digital sequencing panel for quantitative, highly accurate evaluation of cell-free circulating tumor DNA
-
Lanman RB, Mortimer SA, Zill OA, Sebisanovic D, Lopez R, Blau S, et al. Analytical and clinical validation of a digital sequencing panel for quantitative, highly accurate evaluation of cell-free circulating tumor DNA. PLoS One. 2015;10(10):e0140712.
-
(2015)
PLoS One
, vol.10
, Issue.10
-
-
Lanman, R.B.1
Mortimer, S.A.2
Zill, O.A.3
Sebisanovic, D.4
Lopez, R.5
Blau, S.6
-
18
-
-
84943375035
-
Plasma DNA tissue mapping by genome-wide methylation sequencing for noninvasive prenatal, cancer, and transplantation assessments
-
Sun K, Jiang P, Chan KC, Wong J, Cheng YK, Liang RH, et al. Plasma DNA tissue mapping by genome-wide methylation sequencing for noninvasive prenatal, cancer, and transplantation assessments. Proc Natl Acad Sci U S A. 2015;112(40):E5503-12.
-
(2015)
Proc Natl Acad Sci U S A
, vol.112
, Issue.40
, pp. E5503-E5512
-
-
Sun, K.1
Jiang, P.2
Chan, K.C.3
Wong, J.4
Cheng, Y.K.5
Liang, R.H.6
-
19
-
-
84971215883
-
Epigenetic reprogramming of fallopian tube fimbriae in BRCA mutation carriers defines early ovarian cancer evolution
-
Bartlett TE, Chindera K, McDermott J, Breeze CE, Cooke WR, Jones A, et al. Epigenetic reprogramming of fallopian tube fimbriae in BRCA mutation carriers defines early ovarian cancer evolution. Nat Commun. 2016;7:11620.
-
(2016)
Nat Commun
, vol.7
, pp. 11620
-
-
Bartlett, T.E.1
Chindera, K.2
McDermott, J.3
Breeze, C.E.4
Cooke, W.R.5
Jones, A.6
-
20
-
-
84858828509
-
Epigenetic variability in cells of normal cytology is associated with the risk of future morphological transformation
-
Teschendorff AE, Jones A, Fiegl H, Sargent A, Zhuang JJ, Kitchener HC, et al. Epigenetic variability in cells of normal cytology is associated with the risk of future morphological transformation. Genome Med. 2012;4(3):24.
-
(2012)
Genome Med
, vol.4
, Issue.3
, pp. 24
-
-
Teschendorff, A.E.1
Jones, A.2
Fiegl, H.3
Sargent, A.4
Zhuang, J.J.5
Kitchener, H.C.6
-
21
-
-
84861752999
-
Differential variability improves the identification of cancer risk markers in DNA methylation studies profiling precursor cancer lesions
-
Teschendorff AE, Widschwendter M. Differential variability improves the identification of cancer risk markers in DNA methylation studies profiling precursor cancer lesions. Bioinformatics. 2012;28(11):1487-94.
-
(2012)
Bioinformatics
, vol.28
, Issue.11
, pp. 1487-1494
-
-
Teschendorff, A.E.1
Widschwendter, M.2
-
22
-
-
84961357451
-
DNA methylation outliers in normal breast tissue identify field defects that are enriched in cancer
-
Teschendorff AE, Gao Y, Jones A, Ruebner M, Beckmann MW, Wachter DL, et al. DNA methylation outliers in normal breast tissue identify field defects that are enriched in cancer. Nat Commun. 2016;7:10478.
-
(2016)
Nat Commun
, vol.7
, pp. 10478
-
-
Teschendorff, A.E.1
Gao, Y.2
Jones, A.3
Ruebner, M.4
Beckmann, M.W.5
Wachter, D.L.6
-
23
-
-
80053144962
-
A decade of exploring the cancer epigenome - biological and translational implications
-
Baylin SB, Jones PA. A decade of exploring the cancer epigenome - biological and translational implications. Nat Rev Cancer. 2011;11(10):726-34.
-
(2011)
Nat Rev Cancer
, vol.11
, Issue.10
, pp. 726-734
-
-
Baylin, S.B.1
Jones, P.A.2
-
24
-
-
82855163962
-
Genome-scale screen for DNA methylation-based detection markers for ovarian cancer
-
Campan M, Moffitt M, Houshdaran S, Shen H, Widschwendter M, Daxenbichler G, et al. Genome-scale screen for DNA methylation-based detection markers for ovarian cancer. PLoS One. 2011;6(12):e28141.
-
(2011)
PLoS One
, vol.6
, Issue.12
-
-
Campan, M.1
Moffitt, M.2
Houshdaran, S.3
Shen, H.4
Widschwendter, M.5
Daxenbichler, G.6
-
25
-
-
67650077151
-
Circulating methylated SEPT9 DNA in plasma is a biomarker for colorectal cancer
-
deVos T, Tetzner R, Model F, Weiss G, Schuster M, Distler J, et al. Circulating methylated SEPT9 DNA in plasma is a biomarker for colorectal cancer. Clin Chem. 2009;55(7):1337-46.
-
(2009)
Clin Chem
, vol.55
, Issue.7
, pp. 1337-1346
-
-
deVos, T.1
Tetzner, R.2
Model, F.3
Weiss, G.4
Schuster, M.5
Distler, J.6
-
26
-
-
84899550486
-
Novel methylated biomarkers and a robust assay to detect circulating tumor DNA in metastatic breast cancer
-
Fackler MJ, Lopez BZ, Umbricht C, Teo WW, Cho S, Zhang Z, et al. Novel methylated biomarkers and a robust assay to detect circulating tumor DNA in metastatic breast cancer. Cancer Res. 2014;74(8):2160-70.
-
(2014)
Cancer Res
, vol.74
, Issue.8
, pp. 2160-2170
-
-
Fackler, M.J.1
Lopez, B.Z.2
Umbricht, C.3
Teo, W.W.4
Cho, S.5
Zhang, Z.6
-
27
-
-
13944250245
-
Circulating tumor-specific DNA: a marker for monitoring efficacy of adjuvant therapy in cancer patients
-
Fiegl H, Millinger S, Mueller-Holzner E, Marth C, Ensinger C, Berger A, et al. Circulating tumor-specific DNA: a marker for monitoring efficacy of adjuvant therapy in cancer patients. Cancer Res. 2005;65(4):1141-5.
-
(2005)
Cancer Res
, vol.65
, Issue.4
, pp. 1141-1145
-
-
Fiegl, H.1
Millinger, S.2
Mueller-Holzner, E.3
Marth, C.4
Ensinger, C.5
Berger, A.6
-
28
-
-
50349097689
-
Methylated NEUROD1 promoter is a marker for chemosensitivity in breast cancer
-
Fiegl H, Jones A, Hauser-Kronberger C, Hutarew G, Reitsamer R, Jones RL, et al. Methylated NEUROD1 promoter is a marker for chemosensitivity in breast cancer. Clin Cancer Res. 2008;14(11):3494-502.
-
(2008)
Clin Cancer Res
, vol.14
, Issue.11
, pp. 3494-3502
-
-
Fiegl, H.1
Jones, A.2
Hauser-Kronberger, C.3
Hutarew, G.4
Reitsamer, R.5
Jones, R.L.6
-
29
-
-
18544406053
-
DNA methylation in serum of breast cancer patients: an independent prognostic marker
-
Muller HM, Widschwendter A, Fiegl H, Ivarsson L, Goebel G, Perkmann E, et al. DNA methylation in serum of breast cancer patients: an independent prognostic marker. Cancer Res. 2003;63(22):7641-5.
-
(2003)
Cancer Res
, vol.63
, Issue.22
, pp. 7641-7645
-
-
Muller, H.M.1
Widschwendter, A.2
Fiegl, H.3
Ivarsson, L.4
Goebel, G.5
Perkmann, E.6
-
31
-
-
84906828290
-
Validation of a real-time PCR-based qualitative assay for the detection of methylated SEPT9 DNA in human plasma
-
Potter NT, Hurban P, White MN, Whitlock KD, Lofton-Day CE, Tetzner R, et al. Validation of a real-time PCR-based qualitative assay for the detection of methylated SEPT9 DNA in human plasma. Clin Chem. 2014;60(9):1183-91.
-
(2014)
Clin Chem
, vol.60
, Issue.9
, pp. 1183-1191
-
-
Potter, N.T.1
Hurban, P.2
White, M.N.3
Whitlock, K.D.4
Lofton-Day, C.E.5
Tetzner, R.6
-
32
-
-
77951039961
-
DNA methylation based biomarkers in non-invasive cancer screening
-
Shivapurkar N, Gazdar AF. DNA methylation based biomarkers in non-invasive cancer screening. Curr Mol Med. 2010;10(2):123-32.
-
(2010)
Curr Mol Med
, vol.10
, Issue.2
, pp. 123-132
-
-
Shivapurkar, N.1
Gazdar, A.F.2
-
33
-
-
84963971785
-
Methylated circulating tumor DNA in blood: power in cancer prognosis and response
-
Warton K, Mahon KL, Samimi G. Methylated circulating tumor DNA in blood: power in cancer prognosis and response. Endocr Relat Cancer. 2016;23(3):R157-71.
-
(2016)
Endocr Relat Cancer
, vol.23
, Issue.3
, pp. R157-R171
-
-
Warton, K.1
Mahon, K.L.2
Samimi, G.3
-
34
-
-
84905814375
-
DNA methylation markers for early detection of women's cancer: promise and challenges
-
Wittenberger T, Sleigh S, Reisel D, Zikan M, Wahl B, Alunni-Fabbroni M, et al. DNA methylation markers for early detection of women's cancer: promise and challenges. Epigenomics. 2014;6(3):311-27.
-
(2014)
Epigenomics
, vol.6
, Issue.3
, pp. 311-327
-
-
Wittenberger, T.1
Sleigh, S.2
Reisel, D.3
Zikan, M.4
Wahl, B.5
Alunni-Fabbroni, M.6
-
35
-
-
84926492837
-
Cell-free DNA analysis for noninvasive examination of trisomy
-
Norton ME, Jacobsson B, Swamy GK, Laurent LC, Ranzini AC, Brar H, et al. Cell-free DNA analysis for noninvasive examination of trisomy. N Engl J Med. 2015;372(17):1589-97.
-
(2015)
N Engl J Med
, vol.372
, Issue.17
, pp. 1589-1597
-
-
Norton, M.E.1
Jacobsson, B.2
Swamy, G.K.3
Laurent, L.C.4
Ranzini, A.C.5
Brar, H.6
-
36
-
-
84955485152
-
Intra-gene DNA methylation variability is a clinically independent prognostic marker in women's cancers
-
Bartlett TE, Jones A, Goode EL, Fridley BL, Cunningham JM, Berns EM, et al. Intra-gene DNA methylation variability is a clinically independent prognostic marker in women's cancers. PLoS One. 2015;10(12):e0143178.
-
(2015)
PLoS One
, vol.10
, Issue.12
-
-
Bartlett, T.E.1
Jones, A.2
Goode, E.L.3
Fridley, B.L.4
Cunningham, J.M.5
Berns, E.M.6
-
37
-
-
84945132239
-
HOTAIR and its surrogate DNA methylation signature indicate carboplatin resistance in ovarian cancer
-
Teschendorff AE, Lee SH, Jones A, Fiegl H, Kalwa M, Wagner W, et al. HOTAIR and its surrogate DNA methylation signature indicate carboplatin resistance in ovarian cancer. Genome Med. 2015;7(1):108.
-
(2015)
Genome Med
, vol.7
, Issue.1
, pp. 108
-
-
Teschendorff, A.E.1
Lee, S.H.2
Jones, A.3
Fiegl, H.4
Kalwa, M.5
Wagner, W.6
-
38
-
-
84994715829
-
Correlation of smoking-associated DNA methylation changes in buccal cells with DNA methylation changes in epithelial cancer
-
Teschendorff AE, Yang Z, Wong A, Pipinikas CP, Jiao Y, Jones A, et al. Correlation of smoking-associated DNA methylation changes in buccal cells with DNA methylation changes in epithelial cancer. JAMA Oncol. 2015;1(4):476-85.
-
(2015)
JAMA Oncol
, vol.1
, Issue.4
, pp. 476-485
-
-
Teschendorff, A.E.1
Yang, Z.2
Wong, A.3
Pipinikas, C.P.4
Jiao, Y.5
Jones, A.6
-
39
-
-
63149087256
-
Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)
-
Menon U, Gentry-Maharaj A, Hallett R, Ryan A, Burnell M, Sharma A, et al. Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS). Lancet Oncol. 2009;10(4):327-40.
-
(2009)
Lancet Oncol
, vol.10
, Issue.4
, pp. 327-340
-
-
Menon, U.1
Gentry-Maharaj, A.2
Hallett, R.3
Ryan, A.4
Burnell, M.5
Sharma, A.6
-
40
-
-
79952788617
-
Preparation of reduced representation bisulfite sequencing libraries for genome-scale DNA methylation profiling
-
Gu H, Smith ZD, Bock C, Boyle P, Gnirke A, Meissner A. Preparation of reduced representation bisulfite sequencing libraries for genome-scale DNA methylation profiling. Nat Protoc. 2011;6(4):468-81.
-
(2011)
Nat Protoc
, vol.6
, Issue.4
, pp. 468-481
-
-
Gu, H.1
Smith, Z.D.2
Bock, C.3
Boyle, P.4
Gnirke, A.5
Meissner, A.6
-
41
-
-
84892168013
-
Improved reduced representation bisulfite sequencing for epigenomic profiling of clinical samples
-
Lee YK, Jin S, Duan S, Lim YC, Ng DP, Lin XM, et al. Improved reduced representation bisulfite sequencing for epigenomic profiling of clinical samples. Biol Proced Online. 2014;16(1):1.
-
(2014)
Biol Proced Online
, vol.16
, Issue.1
, pp. 1
-
-
Lee, Y.K.1
Jin, S.2
Duan, S.3
Lim, Y.C.4
Ng, D.P.5
Lin, X.M.6
-
42
-
-
0032580320
-
Two-sided confidence intervals for the single proportion: comparison of seven methods
-
Newcombe RG. Two-sided confidence intervals for the single proportion: comparison of seven methods. Stat Med. 1998;17(8):857-72.
-
(1998)
Stat Med
, vol.17
, Issue.8
, pp. 857-872
-
-
Newcombe, R.G.1
-
43
-
-
84888810517
-
Recurrent patterns of DNA methylation in the ZNF154, CASP8, and VHL promoters across a wide spectrum of human solid epithelial tumors and cancer cell lines
-
Sanchez-Vega F, Gotea V, Petrykowska HM, Margolin G, Krivak TC, DeLoia JA, et al. Recurrent patterns of DNA methylation in the ZNF154, CASP8, and VHL promoters across a wide spectrum of human solid epithelial tumors and cancer cell lines. Epigenetics. 2013;8(12):1355-72.
-
(2013)
Epigenetics
, vol.8
, Issue.12
, pp. 1355-1372
-
-
Sanchez-Vega, F.1
Gotea, V.2
Petrykowska, H.M.3
Margolin, G.4
Krivak, T.C.5
DeLoia, J.A.6
-
44
-
-
84960803239
-
Robust detection of DNA hypermethylation of ZNF154 as a pan-cancer locus with in silico modeling for blood-based diagnostic development
-
Margolin G, Petrykowska HM, Jameel N, Bell DW, Young AC, Elnitski L. Robust detection of DNA hypermethylation of ZNF154 as a pan-cancer locus with in silico modeling for blood-based diagnostic development. J Mol Diagn. 2016;18(2):283-98.
-
(2016)
J Mol Diagn
, vol.18
, Issue.2
, pp. 283-298
-
-
Margolin, G.1
Petrykowska, H.M.2
Jameel, N.3
Bell, D.W.4
Young, A.C.5
Elnitski, L.6
-
45
-
-
34248569300
-
Circulating free DNA in plasma or serum as biomarker of carcinogenesis: practical aspects and biological significance
-
Gormally E, Caboux E, Vineis P, Hainaut P. Circulating free DNA in plasma or serum as biomarker of carcinogenesis: practical aspects and biological significance. Mutat Res. 2007;635(2-3):105-17.
-
(2007)
Mutat Res
, vol.635
, Issue.2-3
, pp. 105-117
-
-
Gormally, E.1
Caboux, E.2
Vineis, P.3
Hainaut, P.4
-
46
-
-
84964671215
-
The long and short of circulating cell-free DNA and the ins and outs of molecular diagnostics
-
Jiang P, Lo YM. The long and short of circulating cell-free DNA and the ins and outs of molecular diagnostics. Trends Genet. 2016;32(6):360-71.
-
(2016)
Trends Genet
, vol.32
, Issue.6
, pp. 360-371
-
-
Jiang, P.1
Lo, Y.M.2
-
47
-
-
84988433752
-
Diagnostic accuracy of cancer antigen 125 for endometriosis: a systematic review and meta-analysis
-
Hirsch M, Duffy J, Davis CJ, Nieves PM, Khan KS. Diagnostic accuracy of cancer antigen 125 for endometriosis: a systematic review and meta-analysis. BJOG. 2016;123:1761-8.
-
(2016)
BJOG
, vol.123
, pp. 1761-1768
-
-
Hirsch, M.1
Duffy, J.2
Davis, C.J.3
Nieves, P.M.4
Khan, K.S.5
-
48
-
-
84927948853
-
Population distribution of lifetime risk of ovarian cancer in the United States
-
Pearce CL, Stram DO, Ness RB, Stram DA, Roman LD, Templeman C, et al. Population distribution of lifetime risk of ovarian cancer in the United States. Cancer Epidemiol Biomarkers Prev. 2015;24(4):671-6.
-
(2015)
Cancer Epidemiol Biomarkers Prev
, vol.24
, Issue.4
, pp. 671-676
-
-
Pearce, C.L.1
Stram, D.O.2
Ness, R.B.3
Stram, D.A.4
Roman, L.D.5
Templeman, C.6
-
49
-
-
84977508076
-
Validation of a biomarker panel and longitudinal biomarker performance for early detection of ovarian cancer
-
Simmons AR, Clarke CH, Badgwell DB, Lu Z, Sokoll LJ, Lu KH, et al. Validation of a biomarker panel and longitudinal biomarker performance for early detection of ovarian cancer. Int J Gynecol Cancer. 2016;26(6):1070-7.
-
(2016)
Int J Gynecol Cancer
, vol.26
, Issue.6
, pp. 1070-1077
-
-
Simmons, A.R.1
Clarke, C.H.2
Badgwell, D.B.3
Lu, Z.4
Sokoll, L.J.5
Lu, K.H.6
-
50
-
-
84967239521
-
Comparative analysis of circulating tumor DNA stability in KEDTA, Streck, and Cell Save blood collection tubes
-
Kang Q, Henry NL, Paoletti C, Jiang H, Vats P, Chinnaiyan AM, et al. Comparative analysis of circulating tumor DNA stability in KEDTA, Streck, and Cell Save blood collection tubes. Clin Biochem. 2016;49:1354-60.
-
(2016)
Clin Biochem
, vol.49
, pp. 1354-1360
-
-
Kang, Q.1
Henry, N.L.2
Paoletti, C.3
Jiang, H.4
Vats, P.5
Chinnaiyan, A.M.6
-
51
-
-
85014528183
-
Identification of methylation haplotype blocks aids in deconvolution of heterogeneous tissue samples and tumor tissue-of-origin mapping from plasma DNA
-
Guo S, Diep D, Plongthongkum N, Fung HL, Zhang K, Zhang K. Identification of methylation haplotype blocks aids in deconvolution of heterogeneous tissue samples and tumor tissue-of-origin mapping from plasma DNA. Nat Genet. 2017;49(4):635-42.
-
(2017)
Nat Genet
, vol.49
, Issue.4
, pp. 635-642
-
-
Guo, S.1
Diep, D.2
Plongthongkum, N.3
Fung, H.L.4
Zhang, K.5
Zhang, K.6
-
52
-
-
84962407100
-
Identification of tissue-specific cell death using methylation patterns of circulating DNA
-
Lehmann-Werman R, Neiman D, Zemmour H, Moss J, Magenheim J, Vaknin-Dembinsky A, et al. Identification of tissue-specific cell death using methylation patterns of circulating DNA. Proc Natl Acad Sci U S A. 2016;113(13):E1826-1834.
-
(2016)
Proc Natl Acad Sci U S A
, vol.113
, Issue.13
, pp. E1826-1834
-
-
Lehmann-Werman, R.1
Neiman, D.2
Zemmour, H.3
Moss, J.4
Magenheim, J.5
Vaknin-Dembinsky, A.6
|